Indeed, we detected the RAS–RICTOR interaction not only in resistant cells but also in biopsies of melanoma patients with resistance to BRAF-inhibition, and showed that disruption of the mTORC2–RAS interaction using JR-AB2-011 impeded the proliferation of resistant cells. Here, RICTOR is linked to melanoma.